Blueprint Medicines Correlations

BPMC Stock

USD 95.10 0.47 0.50%

The current 90-days correlation between Blueprint Medicines Corp and Amylyx Pharmaceuticals is 0.17 (i.e., Average diversification). The correlation of Blueprint Medicines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Blueprint Medicines Correlation With Market

Weak diversification

The correlation between Blueprint Medicines Corp and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Blueprint Medicines Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with Blueprint Stock

0.65	VTRS	Viatris	Pair Corr
0.74	WAT	Waters	Pair Corr

Moving against Blueprint Stock

0.58	ZTS	Zoetis Inc	Pair Corr
0.57	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.56	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.52	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.46	HLN	Haleon plc	Pair Corr
0.38	RDY	Dr Reddys Laboratories	Pair Corr
0.36	HCM	HUTCHMED DRC	Pair Corr
0.35	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.31	TAK	Takeda Pharmaceutical	Pair Corr
0.39	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.39	ANRO	Alto Neuroscience,	Pair Corr

Related Correlations Analysis

	TERN	AMLX	ABOS	INZY	XFOR	PTCT	KRYS	ICPT	MDGL	DAWN
TERN		-0.66	-0.12	0.75	0.81	-0.68	0.2	0.52	-0.5	0.03	TERN
AMLX	-0.66		0.49	-0.73	-0.66	0.9	-0.2	-0.69	0.67	0.48	AMLX
ABOS	-0.12	0.49		0.04	0.12	0.34	0.07	-0.06	0.25	0.71	ABOS
INZY	0.75	-0.73	0.04		0.8	-0.72	0.04	0.53	-0.78	0.08	INZY
XFOR	0.81	-0.66	0.12	0.8		-0.69	0.32	0.65	-0.43	0.16	XFOR
PTCT	-0.68	0.9	0.34	-0.72	-0.69		-0.15	-0.68	0.59	0.31	PTCT
KRYS	0.2	-0.2	0.07	0.04	0.32	-0.15		0.52	0.31	0.0	KRYS
ICPT	0.52	-0.69	-0.06	0.53	0.65	-0.68	0.52		-0.22	-0.15	ICPT
MDGL	-0.5	0.67	0.25	-0.78	-0.43	0.59	0.31	-0.22		0.21	MDGL
DAWN	0.03	0.48	0.71	0.08	0.16	0.31	0.0	-0.15	0.21		DAWN
	TERN	AMLX	ABOS	INZY	XFOR	PTCT	KRYS	ICPT	MDGL	DAWN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PTCT	+ 0.9	AMLX
XFOR	+ 0.81	TERN
XFOR	+ 0.8	INZY
INZY	+ 0.75	TERN
DAWN	+ 0.71	ABOS
MDGL	+ 0.67	AMLX

High negative correlations

MDGL	- 0.78	INZY
INZY	- 0.73	AMLX
PTCT	- 0.72	INZY
PTCT	- 0.69	XFOR
ICPT	- 0.69	AMLX
ICPT	- 0.68	PTCT

Risk-Adjusted Indicators

There is a big difference between Blueprint Stock performing well and Blueprint Medicines Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Blueprint Medicines' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TERN	3.39	(0.35)	0.00	(0.23)	0.00	0.00	6.02	(5.96)	34.09
AMLX	4.33	1.51	0.31	1.33	4.07	(5.11)	10.06	(6.13)	33.56
ABOS	3.55	(0.55)	0.00	(0.08)	0.00	0.00	7.52	(6.78)	28.07
INZY	2.76	(1.20)	0.00	(0.59)	0.00	0.00	5.07	(7.92)	16.62
XFOR	5.04	(0.48)	0.00	(0.23)	0.00	0.00	8.82	(10.61)	62.35
PTCT	2.38	0.24	0.11	0.27	2.39	(2.87)	6.61	(4.33)	23.95
KRYS	1.82	(0.17)	(0.05)	0.01	2.13	(2.09)	4.45	(3.75)	12.05
ICPT	2.96	(0.84)	0.00	(1.57)	0.00	0.00	5.23	(8.32)	38.17
MDGL	2.70	0.44	0.15	1.41	2.13	(3.76)	5.17	(3.96)	30.27
DAWN	2.05	(0.11)	0.00	(0.02)	0.00	0.00	3.84	(3.69)	11.44

Blueprint Medicines Corporate Management

Dr MBA	Chief Officer	Profile
Ariel Hurley	Principal Accounting Officer	Profile
Tracey Esq	Chief VP	Profile
Christina Rossi	Chief Commercial Officer	Profile
Michael CPA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC